Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP257528.RAWUD4GwMMy0cSDCeY7o7VwKDmxFziGq1Qg-yecu5pMyc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP257528.RAWUD4GwMMy0cSDCeY7o7VwKDmxFziGq1Qg-yecu5pMyc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP257528.RAWUD4GwMMy0cSDCeY7o7VwKDmxFziGq1Qg-yecu5pMyc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP257528.RAWUD4GwMMy0cSDCeY7o7VwKDmxFziGq1Qg-yecu5pMyc130_provenance.
- NP257528.RAWUD4GwMMy0cSDCeY7o7VwKDmxFziGq1Qg-yecu5pMyc130_assertion description "[Our results suggest that altered mRNA expressions of alpha2,3-sialyltransferase ST3Gal I, ST3Gal III, ST3Gal IV, ST3Gal VI, andalpha2,6-sialyltransferase ST6Gal I are of importance in malignant ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP257528.RAWUD4GwMMy0cSDCeY7o7VwKDmxFziGq1Qg-yecu5pMyc130_provenance.
- NP257528.RAWUD4GwMMy0cSDCeY7o7VwKDmxFziGq1Qg-yecu5pMyc130_assertion evidence source_evidence_literature NP257528.RAWUD4GwMMy0cSDCeY7o7VwKDmxFziGq1Qg-yecu5pMyc130_provenance.
- NP257528.RAWUD4GwMMy0cSDCeY7o7VwKDmxFziGq1Qg-yecu5pMyc130_assertion SIO_000772 16112178 NP257528.RAWUD4GwMMy0cSDCeY7o7VwKDmxFziGq1Qg-yecu5pMyc130_provenance.
- NP257528.RAWUD4GwMMy0cSDCeY7o7VwKDmxFziGq1Qg-yecu5pMyc130_assertion wasDerivedFrom befree-20140225 NP257528.RAWUD4GwMMy0cSDCeY7o7VwKDmxFziGq1Qg-yecu5pMyc130_provenance.
- NP257528.RAWUD4GwMMy0cSDCeY7o7VwKDmxFziGq1Qg-yecu5pMyc130_assertion wasGeneratedBy ECO_0000203 NP257528.RAWUD4GwMMy0cSDCeY7o7VwKDmxFziGq1Qg-yecu5pMyc130_provenance.
- befree-20140225 importedOn "2014-02-25" NP257528.RAWUD4GwMMy0cSDCeY7o7VwKDmxFziGq1Qg-yecu5pMyc130_provenance.